The prognostic value of N-terminal pro-brain natriuretic peptide in non-ST elevation acute coronary syndromes: A meta-analysis

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 4, 2012, Pages 731-739

  Zeng, Xiaocong ^a   Li, Lang ^a   Su, Qiang ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

meta analysis; mortality; N terminal pro brain natriuretic peptide; non ST elevation acute coronary syndromes

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ARTICLE; DEATH; HEART INFARCTION; HUMAN; MORBIDITY; MORTALITY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ACUTE CORONARY SYNDROME; AGED; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84860425143     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.2011.824     Document Type: Article

References (35)

1. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007;28:1598-660.
2. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000;36:970-1062.
3. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiac-specifi c troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-9. (Pubitemid 26360452)
4. Lindahl B, Diderholm E, Lagerqvist B, Venge P, Wallentin L. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol 2001;38:979-86. (Pubitemid 32912698)
5. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998;31:1460-5. (Pubitemid 28273285)
6. Jernberg T, James S, Lindahl B, Stridsberg M, Venge P, Wallentin L. NT-proBNP in unstable coronary artery disease-experiences from the FAST, GUSTO IV and FRISC II trials. Eur J Heart Fail 2004;6:319-25. (Pubitemid 38253052)
7. Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002;106:974-80. (Pubitemid 34925333)
8. Jernberg T, Lindahl B, James S, Larsson A, Hansson LO, Wallentin L. Cystatin C: a novel predictor of outcome in suspected or confi rmed non-ST-elevation acute coronary syndrome. Circulation 2004;110:2342-8. (Pubitemid 39407337)
9. Clerico A Pathophysiological and clinical relevance of circulating levels of cardiac natriuretic hormones: Are they merely markers of cardiac disease ? Clin Chem Lab Med 2002;40:752-60
10. Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001;39: 571-88. (Pubitemid 32725741)
11. Bazzino O, Fuselli JJ, Botto F, Perez De Arenaza D, Bahit C, Dadone J. Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classifi cation and other risk markers in patients with non-ST-elevation acute coronary syndromes. Eur Heart J 2004;25:859-66. (Pubitemid 38679945)
12. Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratifi cation of patients with acute coronary syndromes. Circulation 2004;110:3206-12. (Pubitemid 39525067)
13. James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a global utilization of strategies to open occluded arteries (GUSTO)-IV substudy. Circulation 2003;108:275-81. (Pubitemid 36899016)
14. Jernberg T, Lindahl B, Siegbahn A, Andren B, Frostfeldt G, Lagerqvist B, et al. N-terminal pro-brain natriuretic peptide in relation to infl ammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol 2003;42:1909-16. (Pubitemid 37485564)
15. Kaski JC, Fernandez-Berges DJ, Consuegra-Sanchez L, Fernandez JM, Garcia-Moll X, Mostaza JM, et al. A comparative study of biomarkers for risk prediction in acute coronary syndrome-Results of the SIESTA (Systemic Infl ammation Evaluation in non-ST-elevation Acute coronary syndrome) study. Atherosclerosis 2010;212:636-43.
16. Nørgaard BL, Terkelsen CJ, Riiskjaer M, Holmvang L, Grip L, Heickendorff L, et al. Risk prediction in acute coronary syndrome from serial in-hospital measurements of N-terminal pro-B-type natriuretic peptide. Acute Card Care 2008;10: 159-66.
17. Scirica BM, Sabatine MS, Jarolim P, Murphy SA, de Lemos JL, Braunwald E, et al. Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. Eur Heart J 2011;32:697-705.
18. Windhausen F, Hirsch A, Sanders GT, Cornel JH, Fischer J, van Straalen JP, et al. N-terminal pro-brain natriuretic peptide for additional risk stratifi cation in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy. Am Heart J 2007;153:485-92. (Pubitemid 46440676)
19. Ndrepepa G, Braun S, Mehilli J, Niemoller K, Schomig A, Kastrati A. A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes. Clin Res Cardiol 2007;96:30-7. (Pubitemid 46175368)
20. Nienhuis MB, Ottervanger JP, Bilo HJ, Dikkeschei BD, Zijlstra F. Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc Interv 2008;71:318-24. (Pubitemid 351428148)
21. Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006;144:427-37. (Pubitemid 46768164)
22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88. (Pubitemid 17189972)
23. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997;315:629-34. (Pubitemid 27387172)
24. Eren NK, Ertas F, Yuksek U, Cakir C, Nazli C, Koseoglu M, et al. Additive prognostic value of NT-proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome. Turk Kardiyol Dern Ars 2009;37:1-8.
25. Jarai R, Iordanova N, Jarai F, Raffetseder A, Woloszczuk W, Gyongyosi M, et al. Prediction of clinical outcome in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) using the TIMI risk score extended by N-terminal pro-brain natriuretic peptide levels. Wien Klin Wochenschr 2007;119: 626-32. (Pubitemid 350239507)
26. Navarro Estrada JL, Rubinstein F, Bahit MC, Rolandi F, Perez de Arenaza D, Gabay JM, et al. NT-probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non-ST-elevation acute coronary syndromes. Am Heart J 2006;151:1093 e1-7.
27. Galvani M, Ottani F, Oltrona L, Ardissino D, Gensini GF, Maggioni AP, et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation 2004;110:128-34. (Pubitemid 38924580)
28. Crowe E, Lovibond K, Gray H, Henderson R, Krause T, Camm J. Early management of unstable angina and non-ST segment elevation myocardial infarction: summary of NICE guidance. Br Med J 2010;340:c1134.
29. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 2005;330:625.
30. Costello-Boerrigter LC, Burnett JC Jr. The prognostic value of N-terminal proB-type natriuretic peptide. Nat Clin Pract Cardiovasc Med 2005;2:194-201. (Pubitemid 40812482)
31. Gill D, Seidler T, Troughton RW, Yandle TG, Frampton CM, Richards M, et al. Vigorous response in plasma N-terminal probrain natriuretic peptide (NT-BNP) to acute myocardial infarction. Clin Sci (Lond) 2004;106:135-9. (Pubitemid 38223431)
32. Andreassen AK, Wergeland R, Simonsen S, Geiran O, Guevara C, Ueland T. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension. Am J Cardiol 2006;98:525-9. (Pubitemid 44162883)
33. Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, et al. The infl uence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003;89:745-51. (Pubitemid 36760633)
34. Apple FS, Smith SW, Pearce LA, Murakami MM. Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2009;55:93-100.
35. Mockel M, Danne O, Muller R, Vollert JO, Muller C, Lueders C, et al. Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes. Clin Chim Acta 2008;393:103-9.